Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 146Head and Neck Neoplasms 80Squamous Cell Carcinoma of Head and Neck 69Rectal Neoplasms 46Colonic Neoplasms 42Carcinoma, Non-Small-Cell Lung 39Neoplasm Metastasis 35Neoplasms 25Carcinoma, Squamous Cell 20Pancreatic Neoplasms 17Lung Neoplasms 16Esophageal Neoplasms 15Stomach Neoplasms 12Recurrence 11Laryngeal Neoplasms 11Mouth Neoplasms 10Oropharyngeal Neoplasms 8Esophageal Squamous Cell Carcinoma 8Breast Neoplasms 8Adenocarcinoma Of Esophagus 8Tongue Neoplasms 7Uterine Cervical Neoplasms 6Nasopharyngeal Carcinoma 6Laryngeal Diseases 6Hypopharyngeal Neoplasms 6Colorectal Cancer Metastatic 6Carcinoma 6Adenocarcinoma of Lung 6Salivary Gland Neoplasms 5Cholangiocarcinoma 4

Interventions

Tomography, X-Ray Computed 1Radiotherapy 1Radionuclide Imaging 1Positron-Emission Tomography 1Ibuprofen 1Hydroxyurea 1Fluorouracil 1Electrocardiography 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nose Neoplasms × Cetuximab × Clear all
NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡